Board Moves.

ADMA Biologics (NASDAQ: ADMA)

Appoints Eduardo Rene Salas to the Board of Directors. Mr. Salas is the former Chief Financial Officer at Wellstat Therapeutics.

Apellis Pharmaceuticals (NASDAQ: APLS)

Appoints Keli Walbert to the Board of Directors. Ms. Walbert is the former EVP, US Commercial at Horizon Therapeutics.

Cidara Therapeutics (NASDAQ: CDTX)

Appoints Josh Resnick to the Board of Directors. Mr. Resnick is the Partner and Senior Managing Director at RA Capital Management.

Exact Sciences (NASDAQ: EXAS)

Appoints Kim Popovits to the Board of Directors. Ms. Popovits is the former Chief Executive Officer at Genomic Health.

Gyre Therapeutics (NASDAQ: GYRE)

Appoints Ping Zhang to the Board of Directors. Mr. Zhang is the Managing Partner at String Capital.

NeuroPace (NASDAQ: NPCE)

Appoints Scott Huennekens to the Board of Directors. Mr. Huennekens is the former Chief Executive Officer at Verb Surgical.

Pediatrix Medical Grp (NYSE: MD)

Mark Ordan promoted to CEO continues on the Board of Directors.

Surgery Partners (NASDAQ: SGRY)

Appoints Laura Forese to the Board of Directors. Ms. Forese is the former Chief Operating Officer at New York-Presbyterian Hospital.

Tactile Systems Technology (NASDAQ: TCMD)

Appoints Laura King to the Board of Directors. Ms. King is the Co-Founder and CEO at BiaCure.

‍

‍

‍

Hologic (NASDAQ: HOLX)

Sally Crawford and Scott Garrett to leave the Board of Directors. Ms. Crawford is the former Chief Operating Officer at Healthsource and Mr. Garrett is the Senior Operating Partner at Water Street Healthcare.